1. Home
  2. ZLAB vs HUN Comparison

ZLAB vs HUN Comparison

Compare ZLAB & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$17.59

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Huntsman Corporation

HUN

Huntsman Corporation

HOLD

Current Price

$10.27

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZLAB
HUN
Founded
2013
1970
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2017
2005

Fundamental Metrics

Financial Performance
Metric
ZLAB
HUN
Price
$17.59
$10.27
Analyst Decision
Buy
Hold
Analyst Count
6
11
Target Price
$57.22
$10.23
AVG Volume (30 Days)
827.4K
5.1M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
9.43%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$441,629,000.00
$5,780,000,000.00
Revenue This Year
$30.20
N/A
Revenue Next Year
$34.71
$3.40
P/E Ratio
N/A
N/A
Revenue Growth
24.14
N/A
52 Week Low
$17.72
$7.30
52 Week High
$44.34
$19.57

Technical Indicators

Market Signals
Indicator
ZLAB
HUN
Relative Strength Index (RSI) 17.58 59.51
Support Level $19.40 $9.72
Resistance Level $18.67 $11.14
Average True Range (ATR) 0.50 0.54
MACD 0.07 0.05
Stochastic Oscillator 3.05 61.70

Price Performance

Historical Comparison
ZLAB
HUN

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

Share on Social Networks: